Medication info
Bilguard M Tablets 50/500mg

Bilguard M Tablets 50/500mg

Prescription medicationTabletOral
Ingredient · strength
Vildagliptin›50mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Samjin Pharmaceutical Co., Ltd.
Appearance
Bright yellow oval film-coated tablets
Packaging
30 tablets/box [10 tablets/PTP X3]
Approval status
Active

MFDS item code 202107101 · Approved 2021.10.25 · Insurance code 647805260

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
For the treatment of patients with type 2 diabetes mellitus, the dose of this medicine should be individualized based on efficacy and tolerability, without exceeding 100mg of vildagliptin and 2000mg of metformin. Doses of vildagliptin greater than 100mg/day are not recommended. This medicine is generally administered with food or immediately after a meal to reduce gastrointestinal adverse reactions caused by metformin. 1. Patients with no previous experience of antidiabetic drug therapy for whom adequate glycemic control is difficult to achieve with monotherapy: The initial dose is 1 tablet of this medicine 50/500mg once daily. The dose may be gradually increased to 1 tablet of 50/1000mg twice daily. 2. Patients switching from combination therapy with vildagliptin and metformin: Patients switching from combination therapy with vildagliptin and metformin to this medicine may start at their existing doses of vildagliptin and metformin. No studies have been conducted to evaluate the safety and efficacy of switching from another oral hypoglycemic agent to this medicine. Any change in the treatment regimen for type 2 diabetes mellitus may affect glycemic control; therefore, caution and appropriate monitoring are required. If you miss a dose of this medicine, take it with your next meal unless it is time to take the missed dose. Do not take a double dose at one time to make up for a missed dose. Patients with hepatic impairment This medicine is not recommended for patients with clinical or laboratory evidence of hepatic impairment, including patients whose ALT or AST levels exceed 2.5 times the upper limit of normal before starting treatment.

Ingredients

Manufacturer
Samjin Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used to assist in blood sugar control for patients with type 2 diabetes who are taking vildagliptin and metformin together. It helps to manage blood sugar more effectively when combined with dietary changes and exercise. This helps stabilize blood sugar levels for patients, contributing to their overall health.

How to take

Adult dose

For the treatment of patients with type 2 diabetes mellitus, the dose of this medicine should be individualized based on efficacy and tolerability, without exceeding 100mg of vildagliptin and 2000mg of metformin. Doses of vildagliptin greater than 100mg/day are not recommended. This medicine is generally administered with food or immediately after a meal to reduce gastrointestinal adverse reactions caused by metformin. 1. Patients with no previous experience of antidiabetic drug therapy for whom adequate glycemic control is difficult to achieve with monotherapy: The initial dose is 1 tablet of this medicine 50/500mg once daily. The dose may be gradually increased to 1 tablet of 50/1000mg twice daily. 2. Patients switching from combination therapy with vildagliptin and metformin: Patients switching from combination therapy with vildagliptin and metformin to this medicine may start at their existing doses of vildagliptin and metformin. No studies have been conducted to evaluate the safety and efficacy of switching from another oral hypoglycemic agent to this medicine. Any change in the treatment regimen for type 2 diabetes mellitus may affect glycemic control; therefore, caution and appropriate monitoring are required. If you miss a dose of this medicine, take it with your next meal unless it is time to take the missed dose. Do not take a double dose at one time to make up for a missed dose. Patients with hepatic impairment This medicine is not recommended for patients with clinical or laboratory evidence of hepatic impairment, including patients whose ALT or AST levels exceed 2.5 times the upper limit of normal before starting treatment.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so it should not be used especially in patients with moderate to severe renal impairment or heart failure. The medication should be discontinued in patients undergoing radiologic iodine contrast studies and can only be restarted after confirming normal renal function post-examination. Patients with a history of hypersensitivity to this medication or those with type 1 diabetes or diabetic ketoacidosis should not use it. Patients with severe infections, significant trauma, nutritional deficits, liver dysfunction, severe pulmonary diseases, or excessive alcohol consumption should either temporarily discontinue or use this medication with caution. It is advisable for pregnant or breastfeeding women to avoid using this medication. This medication carries a risk of hypoglycemia, so caution is required in cases of irregular meals, intense exercise, or when used in combination with other blood sugar-lowering agents. Possible adverse reactions during use include headaches, dizziness, nausea, and hypoglycemia, and if there are signs of liver dysfunction or skin reactions, one should consult healthcare professionals immediately. Patients should have regular checks of liver and kidney function, especially the elderly or those with reduced kidney function should be more cautious. Alcohol consumption can increase the risk of lactic acidosis, so it should be avoided during treatment. Caution is also necessary when driving or operating machinery due to possible dizziness or hypoglycemic symptoms. In case of overdose, one should promptly visit a medical facility for appropriate treatment, and while this medication can be removed by hemodialysis, some components may not be. This medication is not recommended for children or adolescents under 18 years of age, and dosage adjustment is necessary for the elderly depending on kidney function. It is important to monitor blood glucose and blood counts regularly during the course of treatment.

Side effects

  • Lactic acidosis
  • hypoglycemia
  • hepatitis
  • impaired liver function
  • elevated transaminase levels
  • angioedema
  • tremors
  • headache
  • dizziness
  • fatigue
Show 43 more
  • nausea
  • gastroesophageal reflux
  • diarrhea
  • bloating
  • chills
  • decreased blood sugar
  • asthenia
  • sweating
  • constipation
  • arthralgia
  • upper respiratory tract infections
  • pharyngitis
  • peripheral edema
  • dyspepsia
  • abdominal discomfort
  • gastrointestinal disturbances
  • increased serum amylase
  • increased lipase
  • pancreatitis
  • urticaria
  • blisters
  • desquamative skin lesions
  • severe and disabling arthralgia
  • cutaneous vasculitis
  • blistering dermatitis herpetiformis
  • myalgia
  • paresthesia
  • fever
  • edema
  • elevated creatine phosphokinase
  • elevated AST
  • increased C-reactive protein
  • elevated myoglobin levels
  • hand and foot edema
  • hypoxia
  • dehydration
  • diarrhea
  • vomiting
  • gastrointestinal disturbances
  • skin lesions
  • vesicles
  • ulcers
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may deteriorate when exposed to air or moisture, so it must be stored in a tightly sealed container. It is recommended to keep it at room temperature, between 1 and 30 degrees Celsius, to maintain its efficacy for a longer duration.

Appearance and packaging

Appearance

Bright yellow oval film-coated tablets

Package unit

30 tablets/box [10 tablets/PTP X3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.